Best of Hematology and Breast Cancer 2026 - Boise
In-Person Event
Feb 28, 2026
Boise, Idaho, USA
6.75 AMA PRA Category 1 Credits™ ...Speakers
OVERVIEW
Best of Hematology and Breast Cancer 2026 is organized by Binaytara Foundation (BTF) and will be held on Feb 28, 2026 in Boise, Idaho, United States of America.
Description:
The Best of Hematology and Breast Cancer 2026 in Boise is a premier CME/CE-accredited hematology and oncology conference designed for physicians, advanced practitioners, pharmacists, nurses, and the entire cancer care team. This annual oncology symposium delivers the most up-to-date clinical insights in hematologic malignancies and breast cancer, ensuring participants can translate research into practice.
Through a mix of didactic lectures, interactive tumor boards, case-based discussions, and expert debates, attendees will explore evolving standards of care, new therapeutic strategies, and evidence-based approaches to improve outcomes.
By emphasizing a multidisciplinary approach, the conference fosters collaboration across specialties and includes dedicated opportunities for networking with peers, faculty, and industry partners through exhibits, receptions, and informal exchanges.
Conference Highlights
- Accreditation: Earn CME/CE credits for physicians, nurses, and pharmacists.
- Interactive Learning: Case-based sessions, tumor board-style reviews, and faculty-led debates.
- Multidisciplinary Focus: Practical insights for oncologists, hematologists, APPs, pharmacists, and nurses.
- Evidence to Practice: Strategies to integrate clinical trial findings into everyday cancer care.
- Networking: Exhibit hall, peer collaboration, and receptions with thought leaders.
Learning Objectives:
By the end of this hematology and oncology conference, participants will be able to:
- Summarize the most clinically relevant updates from ASH25 and SABCS25 and their impact on hematology and breast cancer care.
- Evaluate emerging therapeutic strategies, including indications, contraindications, and potential to improve patient outcomes.
- Critically analyze recent clinical trial data and guideline updates to determine their role in current standards of care.
- Integrate advances in diagnostics, prognostics, and treatment into personalized, evidence-based management of patients with hematologic disorders and breast cancer.
KEY DATES
28 Feb, 2026
Event Start Date
28 Feb, 2026
Event End Date
ACCREDITATION & CREDITS
Accreditation
6.75 AMA PRA Category 1 Credit™
The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of 6.75 Best of Hematology and Breast Cancer 2026, Boise. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.75 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
6.75 ABIM MOC II
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
6.75 ACPE Pharmacy
The Binaytara is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number assigned to the activity is Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Best of Hematology and Breast Cancer 2026, Boise activity will not be awarded the CEUs. The Binaytara may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®. After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.
6.75 Nursing Contact Hours
Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.75 Contact Hours.
TARGET AUDIENCE
PhysicianNursingPharmacistPhysician AssistantOncologistsAdvanced Practitioner NursesNursesHematologistNurse PractitionersRadiation OncologistsSPECIALITIES
HematologySurgical OncologySUGGESTED HOTELS
CONFERENCE VENUE
TBD
Quick Links